I

Ilyang Pharmaceutical Co Ltd
KRX:007570

Watchlist Manager
Ilyang Pharmaceutical Co Ltd
KRX:007570
Watchlist
Price: 13 050 KRW
Market Cap: 254.9B KRW

Wall Street
Price Targets

Price Targets Summary
Ilyang Pharmaceutical Co Ltd

There are no price targets for Ilyang Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Ilyang Pharmaceutical Co Ltd Competitors:
Price Targets
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
2% Upside
SNDL
Sundial Growers Inc
250% Upside
ALKEM
Alkem Laboratories Ltd
4% Upside
MVP
Medical Developments International Ltd
58% Upside
DMP
Dermapharm Holding SE
12% Upside
ERIS
Eris Lifesciences Ltd
24% Upside
VETO
Vetoquinol SA
8% Upside
4519
Chugai Pharmaceutical Co Ltd
6% Upside

Revenue
Forecast

Revenue Estimate
Ilyang Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Ilyang Pharmaceutical Co Ltd's revenue is 0%. The projected CAGR for the next 6 years is 2%.

0%
Past Growth
2%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Ilyang Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Ilyang Pharmaceutical Co Ltd's operating income is -9%. The projected CAGR for the next 6 years is 12%.

-9%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Net Income
Forecast

Net Income Estimate
Ilyang Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Ilyang Pharmaceutical Co Ltd's net income is 7%. The projected CAGR for the next 6 years is -3%.

7%
Past Growth
-3%
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Ilyang Pharmaceutical Co Ltd's stock price target?
Not Available

Ilyang Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Ilyang Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
2%

For the last 8 years the compound annual growth rate for Ilyang Pharmaceutical Co Ltd's revenue is 0%. The projected CAGR for the next 6 years is 2%.

What is Ilyang Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Ilyang Pharmaceutical Co Ltd's operating income is -9%. The projected CAGR for the next 6 years is 12%.

What is Ilyang Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-3%

For the last 8 years the compound annual growth rate for Ilyang Pharmaceutical Co Ltd's net income is 7%. The projected CAGR for the next 6 years is -3%.

Back to Top